136 related articles for article (PubMed ID: 8993544)
1. Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon.
Reddy JK; Chu R
Ann N Y Acad Sci; 1996 Dec; 804():176-201. PubMed ID: 8993544
[No Abstract] [Full Text] [Related]
2. Relationship of peroxisome proliferator-induced cellular effects to hepatocarcinogenesis.
Popp JA; Cattley RC; Miller RT; Marsman DS
Prog Clin Biol Res; 1994; 387():193-207. PubMed ID: 7972246
[No Abstract] [Full Text] [Related]
3. Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia.
Bell AR; Savory R; Horley NJ; Choudhury AI; Dickins M; Gray TJ; Salter AM; Bell DR
Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):689-93. PubMed ID: 9620871
[TBL] [Abstract][Full Text] [Related]
4. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
[TBL] [Abstract][Full Text] [Related]
5. The role of peroxisome proliferator activated receptor alpha in peroxisome proliferation, physiological homeostasis, and chemical carcinogenesis.
Gonzalez FJ
Adv Exp Med Biol; 1997; 422():109-25. PubMed ID: 9361819
[No Abstract] [Full Text] [Related]
6. Interplay of the peroxisome proliferator-activated receptor and the thyroid hormone receptor-signaling pathways in regulating peroxisome proliferator-responsive genes.
Winrow CJ; Kassam A; Miyata KS; Marcus SL; Hunter J; Capone JP; Rachubinski RA
Ann N Y Acad Sci; 1996 Dec; 804():214-30. PubMed ID: 8993546
[No Abstract] [Full Text] [Related]
7. Hydrogen peroxide metabolism during peroxisome proliferation by fenofibrate.
Arnaiz SL; Travacio M; Llesuy S; Boveris A
Biochim Biophys Acta; 1995 Dec; 1272(3):175-80. PubMed ID: 8541349
[TBL] [Abstract][Full Text] [Related]
8. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats.
Moya-Camarena SY; Van den Heuvel JP; Belury MA
Biochim Biophys Acta; 1999 Jan; 1436(3):331-42. PubMed ID: 9989264
[TBL] [Abstract][Full Text] [Related]
9. Studies on the role of PPAR in the fibrate-modulated gene expression of apolipoprotein A-I, plasminogen activator inhibitor 1, and fibrinogen in primary hepatocyte cultures from cynomolgus monkey.
Kockx M; Princen HM; Kooistra T
Ann N Y Acad Sci; 1996 Dec; 804():711-2. PubMed ID: 8993601
[No Abstract] [Full Text] [Related]
10. Carcinogenicity of lipid-lowering drugs.
Cattley RC
JAMA; 1996 May; 275(19):1479; author reply 1481-2. PubMed ID: 8622215
[No Abstract] [Full Text] [Related]
11. Perplexing peroxisome proliferators.
Citron M
Environ Health Perspect; 1995 Mar; 103(3):232-5. PubMed ID: 7768221
[No Abstract] [Full Text] [Related]
12. PPAR alpha structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents.
Keller H; Devchand PR; Perroud M; Wahli W
Biol Chem; 1997 Jul; 378(7):651-5. PubMed ID: 9278144
[TBL] [Abstract][Full Text] [Related]
13. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
Li Y; Leung LK; Glauert HP; Spear BT
Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
[TBL] [Abstract][Full Text] [Related]
14. The peroxisome proliferator-activated receptors: ligands and activators.
Forman BM; Chen J; Evans RM
Ann N Y Acad Sci; 1996 Dec; 804():266-75. PubMed ID: 8993549
[TBL] [Abstract][Full Text] [Related]
15. Sex-dependent regulation of hepatic peroxisome proliferation in mice by trichloroethylene via peroxisome proliferator-activated receptor alpha (PPARalpha).
Nakajima T; Kamijo Y; Usuda N; Liang Y; Fukushima Y; Kametani K; Gonzalez FJ; Aoyama T
Carcinogenesis; 2000 Apr; 21(4):677-82. PubMed ID: 10753203
[TBL] [Abstract][Full Text] [Related]
16. A knockout for risk assessment.
Bell DR
Hum Exp Toxicol; 1995 Oct; 14(10):850-1. PubMed ID: 8562126
[No Abstract] [Full Text] [Related]
17. Delineating peroxisome proliferator action to improve human risk assessment.
Green S; Issemann I; Tugwood JD; Prince RA; Aldridge TC
Prog Clin Biol Res; 1994; 387():311-33. PubMed ID: 7972256
[No Abstract] [Full Text] [Related]
18. Structural diversity of peroxisome proliferators and their effects on mammalian liver cells in vivo.
de la Iglesia F; McGuire EJ; Haskins JR; Lalwani ND
Ann N Y Acad Sci; 1996 Dec; 804():310-27. PubMed ID: 8993553
[No Abstract] [Full Text] [Related]
19. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
20. Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate.
Nilakantan V; Spear BT; Glauert HP
Carcinogenesis; 1998 Apr; 19(4):631-7. PubMed ID: 9600348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
